GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (MIL:1GILD) » Definitions » Other Current Liabilities

Gilead Sciences (MIL:1GILD) Other Current Liabilities : €4,269 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Gilead Sciences Other Current Liabilities?

Gilead Sciences's other current liabilities for the quarter that ended in Mar. 2025 was €4,269 Mil.

Gilead Sciences's quarterly other current liabilities increased from Sep. 2024 (€3,027 Mil) to Dec. 2024 (€3,646 Mil) and increased from Dec. 2024 (€3,646 Mil) to Mar. 2025 (€4,269 Mil).

Gilead Sciences's annual other current liabilities increased from Dec. 2022 (€3,419 Mil) to Dec. 2023 (€3,596 Mil) and increased from Dec. 2023 (€3,596 Mil) to Dec. 2024 (€3,646 Mil).


Gilead Sciences Other Current Liabilities Historical Data

The historical data trend for Gilead Sciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Other Current Liabilities Chart

Gilead Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,192.72 1,262.01 3,419.17 3,596.47 3,646.19

Gilead Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,004.72 3,014.61 3,027.36 3,646.19 4,268.88

Gilead Sciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Gilead Sciences Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Gilead Sciences Business Description

Address
333 Lakeside Drive, Foster City, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Gilead Sciences Headlines

No Headlines